NERVGEN PHARMA CORP - stock earnings
NGEN.V Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.3 million CAD | ? CAD |
| 2023Q2 | -4.8 million CAD | ? CAD |
| 2023Q1 | -4.7 million CAD | ? CAD |
| 2022Q4 | -5.9 million CAD | ? CAD |
| 2022Q3 | -3.5 million CAD | ? CAD |
| 2022Q2 | -6.3 million CAD | ? CAD |
| 2022Q1 | -5.0 million CAD | ? CAD |
| 2021Q4 | -4.1 million CAD | ? CAD |
| 2021Q3 | -3.6 million CAD | ? CAD |
| 2021Q2 | -2.7 million CAD | ? CAD |
| 2021Q1 | -2.2 million CAD | ? CAD |
| 2020Q4 | -4.6 million CAD | ? CAD |
| 2020Q3 | -2.1 million CAD | ? CAD |
| 2020Q2 | -2.6 million CAD | ? CAD |
| 2020Q1 | -1.9 million CAD | ? CAD |
| 2019Q4 | -2.9 million CAD | ? CAD |
| 2019Q3 | -2.3 million CAD | ? CAD |
| 2019Q2 | -1.5 million CAD | ? CAD |
| 2019Q1 | -3.0 million CAD | ? CAD |
| 2018Q4 | -767968 CAD | ? CAD |
| 2018Q3 | -515541 CAD | ? CAD |
| 2018Q2 | -64350 CAD | ? CAD |
NGEN.V Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -19.7 million CAD | ? CAD |
| 2022 | -20.7 million CAD | ? CAD |
| 2021 | -12.7 million CAD | ? CAD |
| 2020 | -11.2 million CAD | ? CAD |
| 2019 | -9.8 million CAD | ? CAD |
| 2018 | -1.4 million CAD | ? CAD |
| 2017 | -11813 CAD | ? CAD |
NGEN.V
Price: CA$2.05
52 week price:
Earnings Per Share: -0.33 CAD
P/E Ratio: -11.42
Exchange: VAN
Sector: Healthcare
Industry: Biotechnology
Volume: 70700
Market Capitalization: 131.5 million